increas multi-year core revenu growth outlook base larg assumpt
built out-grow peer group bigger magnitud target
least line ahead investor expect meet also serv highlight
reinforc strong competit posit attract outlook continu
view core long-term hold
thermo fisher financi track record superb report revenu adjust
ep compound-annual-growth-rate sinc approxim respect
rate among top tier within tool group bear may point
report growth rate boost activ peer
note compani typic perform better measur revenu growth
margin stand-alone compani manag provid sever
exampl includ fei patheon
report earlier link note updat financi target oper
margin convers ep line expect notabl
increas organ revenu growth target least
good expect bit better detail target herein
similar past analyst day manag outlin thermo fisher growth strategi
includ three key tenet remain unchang high impact innovation/r
scale high growth/emerg market uniqu custom valu proposit
view manag solid job outlin compani growth playbook formula
success well provid clear exampl substanti valid growth
continu impress thermo fisher consist consist growth
strategi manag team execut result well-oil machin
gener outperform peer key metric variou econom cycles/discret
headwind past decad high convict meet exceed
updat financi target would posit compani outgrow
forecast peer group averag share today trade less discount p/
 basi past note dcf analysi execution/outlook
much larger capac support higher multipl valuat reiter
outperform rate price target
continu page
pleas see page report import disclosur
remain enthus outlook continu expect peer group
averag revenu ep growth long term near term expect
beat revenu ep guidanc particularli given capac exce
continu one favorit tool stock
ep upsid year
ep upsid year
ep upsid year
thermo fisher engag serv scienc provid analyt instrument equip
reagent consum softwar servic research manufactur analysi
discoveri diagnost oper four segment life scienc solut lss
analyt instrument ai specialti diagnost sdx laboratori product
servic lp lss segment larg consist acquir busi
 deliv rang product servic use across life scienc
appli market diagnost
similar past analyst day manag kick meet overview
compani profil review histor perform organ
inorgan invest thermo fisher transform consider past
year manag highlight higher growth/mor attract market
product class pharma/biotech revenu today vs china
revenu today vs recur revenu constitut greater
portion compani today transform contribut strong financi
perform sinc report revenu adjust ep compound-annual-growth-rate
approxim respect growth rate among top
tier within tool group indic tmo long track record success
increas annual organ revenu growth target
note preview report expect least increas
believ updat target also least line investor expect
target increment growth rel market prior manag
continu assum market growth rate approxim
oper margin expect approxim repres
annual underli margin expans increment benefit complet
acquisit larg line our/consensu expect
convers expect approxim chang vs last year line
expect annual growth expect equal adjust ep growth
without increment expect improv annual
annual improv expect assumpt
manag expect approxim
ep includ impact assum capit deploy share
repurchas dividend expect approxim
midpoint line preview report expect ahead
current publish consensu estim sell-sid forecast gener includ
impact unannounc manag financi model assum
compani deploy capit period alloc
 share buybacks/dividend dividend expect increas
similar past analyst day manag outlin thermo fisher growth strategi
includ three key tenet remain unchang high impact
innovation/r scale high growth/emerg market uniqu custom
thermo fisher invest annual absolut dollar largest
 budget tool industri theme innov highlight throughout
present manag provid numer exampl new
innov product enabl key scientif advanc gene/cel therapi
precis medicin structur biolog also note innov
particularli area mass spectrometri liquid chromatographi vanquish
uhplc electron microscopi enabl thermo fisher gain signific market
share manag agre assert
also encourag hear tmo four main busi segment collabor
intern develop solut support notion busi segment
complementari perform better umbrella one notabl
rel newer exampl bioproduct life scienc solut segment
work close patheon/pharma servic lab product servic segment
identifi areas/product requir innov pharma servic larg custom
bioproduct product
thermo fisher unparallel scale commerci manufactur support
infrastructur geographi includ high growth/emerg market
ltm revenu last year analyst day scale contribut
strong revenu growth emerg market particularli china support
sustain high growth rate futur believ could also explain
thermo fisher meaning impact growth headwind
peer face china past sever quarter thermo fisher much
diversifi local busi close align china govern strateg
thermo fisher scale broad divers product/servic portfolio expertis help
deliv uniqu valu proposit custom similar last year manag
highlight compani strong track record biopharma end market
exampl leverag uniqu valu proposit gain market share
note tmo scale relationship/access custom typic enhanc
subsequ
 remain key compon tmo growth strategi manag estim
top player tool market constitut total revenu
hundr smaller compani remain consolid year
manag increas total tool market opportun last
year year plenti opportun remain
even without enter new vertic importantli take method
calcul approach evalu execut opportun
import criteria acquisit enhanc tmo custom offer strengthen
strateg posit creat sharehold valu
manag financi model assum compani deploy capit
 avail capit period believ
compani stretch beyond need
manag provid sever exampl compani enhanc
perform recent larger thermo fisher ownership includ life
technolog revenu growth increas lsd pre-acquisit msd-hsd today
fei revenu growth improv lsd-msd msd-hsd patheon revenu
growth improv msd hsd systemat integr process
note acquir compani benefit tremend compani practic
process improv ppi busi system believ tmo track record
integr capabl bode well futur acquisit stock price
compani report cowen compani
mm except yr cagrtot scienc product growth growth currenc growth scienc growth growth net growth growth net growth growth net product servic growth growth net growth cowen
compani report thomson eikon cowen compani
mm except per share cagrcommentsnet organ organ fx reiter bd ap brammer organ growth rate similar though one fewer day patheon expect benefit order year compound-annual-growth-rate organ revenu growthcost gener oper includ tariff ap margin bit weight fx less headwind increment net interest expens reiter though closer add earn per brammer fx share quarterli phase similar share gross op cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
risk includ limit macroeconom deterior current
level inabl execut integr eros market share price due
competit inabl deliv incremental/decrement margin target value-
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock thermo fisher scientif secur
cowen compani llc manag co-manag public offer past month
cowen compani llc receiv compens invest bank servic past month
cowen compani llc and/or affili expect receiv intend seek compens invest bank servic next month
past month client cowen compani llc cowen compani llc provid provid invest bank servic
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
